论文部分内容阅读
目的:评价鼻塞持续气道正压通气(NCPAP)治疗早产儿呼吸暂停(apnea of prematurity,AOP)的疗效。方法:82例呼吸暂停的早产儿随机分为两组,治疗组42例用NCPAP,对照组40例用氨茶碱加纳络酮,观察比较两组疗效。结果:治疗组的显效率、总有效率分别为61.9%、92.8%,对照组为32.5%、67.5%,两组差异具有统计学意义(P<0.01)。结论:NCPAP可有效治疗AOP,且疗效优于氨茶碱加纳络酮。
Objective: To evaluate the efficacy of nasal continuous positive airway pressure (NCPAP) in the treatment of apnea of prematurity (AOP). Methods: Eighty-two preterm infants with apnea were randomly divided into two groups. NCPAP was used in 42 cases and aminophylline plus naloxone in 40 cases in control group. The curative effect was observed and compared between the two groups. Results: The effective rate and total effective rate of the treatment group were 61.9% and 92.8%, respectively, while the control group was 32.5% and 67.5% respectively. There was significant difference between the two groups (P <0.01). Conclusion: NCPAP can effectively treat AOP, and its efficacy is better than that of aminophylline and naloxone.